KOPS - Das Institutionelle Repositorium der Universität Konstanz

Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases

Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases

Zitieren

Dateien zu dieser Ressource

Dateien Größe Format Anzeige

Zu diesem Dokument gibt es keine Dateien.

BERGER, Nathan A, Valerie C BESSON, A Hamid BOULARES, Alexander BÜRKLE, Alberto CHIARUGI, Robert S CLARK, Nicola J. CURTIN, Salvatore CUZZOCREA, Ted M DAWSON, Csaba SZABO, 2018. Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases. In: British journal of pharmacology. 175(2), pp. 192-222. ISSN 0366-0826. eISSN 1476-5381. Available under: doi: 10.1111/bph.13748

@article{Berger2018Oppor-41708, title={Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases}, year={2018}, doi={10.1111/bph.13748}, number={2}, volume={175}, issn={0366-0826}, journal={British journal of pharmacology}, pages={192--222}, author={Berger, Nathan A and Besson, Valerie C and Boulares, A Hamid and Bürkle, Alexander and Chiarugi, Alberto and Clark, Robert S and Curtin, Nicola J. and Cuzzocrea, Salvatore and Dawson, Ted M and Szabo, Csaba} }

<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/41708"> <dc:contributor>Berger, Nathan A</dc:contributor> <dc:creator>Besson, Valerie C</dc:creator> <dc:creator>Chiarugi, Alberto</dc:creator> <dc:creator>Cuzzocrea, Salvatore</dc:creator> <dc:language>eng</dc:language> <dcterms:title>Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases</dcterms:title> <dc:contributor>Szabo, Csaba</dc:contributor> <dc:contributor>Bürkle, Alexander</dc:contributor> <dc:creator>Clark, Robert S</dc:creator> <dc:creator>Dawson, Ted M</dc:creator> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dc:contributor>Clark, Robert S</dc:contributor> <dc:contributor>Cuzzocrea, Salvatore</dc:contributor> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dc:creator>Boulares, A Hamid</dc:creator> <dc:creator>Berger, Nathan A</dc:creator> <dcterms:abstract xml:lang="eng">The recent clinical availability of the PARP inhibitor olaparib (Lynparza) opens the door for potential therapeutic repurposing for non-oncological indications. Considering (a) the preclinical efficacy data with PARP inhibitors in non-oncological diseases and (b) the risk-benefit ratio of treating patients with a compound that inhibits an enzyme that has physiological roles in the regulation of DNA repair, we have selected indications, where (a) the severity of the disease is high, (b) the available therapeutic options are limited, and (c) the duration of PARP inhibitor administration could be short, to provide first-line options for therapeutic repurposing. These indications are as follows: acute ischaemic stroke; traumatic brain injury; septic shock; acute pancreatitis; and severe asthma and severe acute lung injury. In addition, chronic, devastating diseases, where alternative therapeutic options cannot halt disease development (e.g. Parkinson's disease, progressive multiple sclerosis or severe fibrotic diseases), should also be considered. We present a preclinical and clinical action plan for the repurposing of PARP inhibitors.</dcterms:abstract> <dc:contributor>Chiarugi, Alberto</dc:contributor> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/41708"/> <dc:contributor>Dawson, Ted M</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-03-07T09:55:25Z</dcterms:available> <dc:creator>Szabo, Csaba</dc:creator> <dc:contributor>Besson, Valerie C</dc:contributor> <dc:contributor>Boulares, A Hamid</dc:contributor> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-03-07T09:55:25Z</dc:date> <dc:contributor>Curtin, Nicola J.</dc:contributor> <dcterms:issued>2018</dcterms:issued> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:creator>Curtin, Nicola J.</dc:creator> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dc:creator>Bürkle, Alexander</dc:creator> </rdf:Description> </rdf:RDF>

Das Dokument erscheint in:

KOPS Suche


Stöbern

Mein Benutzerkonto